Download the report and...
About this report
By 2028, the value of the global cell therapy market is projected to surpass $45B, up from less than $20B in 2020. Some industry insiders even anticipate that cell and gene therapies will overtake conventional drug therapies in the not-so-distant future, with sales projected to significantly increase by 2026.
This report gives an overview of the global cell therapy landscape, highlighting several players in the space; key licensing deals and investments; and the effect of the Covid-19 pandemic on the industry. It also takes a closer look at what cell therapy entails, from delineating the different subtypes to the different medical fields employing cell therapies. A particular focus is placed on adoptive cell therapies, including CAR-T cell therapy, which have seen a major influx in interest in the previous years.